Business Context and Reporting Period
Greatbatch, Inc. filed this Form 8-K on March 19, 2007, to disclose a material corporate event. The filing reports the execution of a definitive agreement to acquire substantially all assets of BIOMEC, Inc.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period. The only specific financial figure disclosed relates to the transaction:
- Acquisition Consideration: $11.4 million in cash plus future additional considerations.
- Funding Source: Existing cash and short-term investments on hand.
Material Changes
The primary material change is the pending acquisition of BIOMEC, Inc. This transaction is subject to BIOMEC shareholder approval. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the agreement. The filing notes a specific contingency: the transaction is conditional upon BIOMEC shareholder approval. No forward-looking guidance, risk factors, or unusual items beyond the acquisition are detailed in this specific report.
Investor Verification Checklist
- Confirm the status of BIOMEC shareholder approval required to close the deal.
- Verify the specific terms and valuation of the "future additional considerations" mentioned in the agreement.
- Review the full text of the press release (Exhibit 99.1) for strategic rationale and integration plans.
- Assess the impact of the $11.4 million cash outflow on Greatbatch's remaining liquidity and working capital.